Sight Diagnostics raises $71M Series D

The Olo system [Image courtesy of Sight Diagnostics]

Blood diagnostic testing developer Sight Diagnostics announced this week that it raised $71 million in a Series D financing round.

Koch Disruptive Technologies, Longliv Ventures and OurCrowd participated in the round, bringing Sight Diagnostics’ total funding to more than $124 million, according to a news release.

Tel Aviv, Israel-based Sight Diagnostics said the funding will support its commercial operations around the world while also advancing its R&D into the detection of new diseases, as well as the blood factors affecting the severity of COVID-19.

“This new investment will enable Sight to substantially expand our U.S. footprint and help usher in a new era of AI-driven diagnostics for a myriad of diseases and health conditions,” Sight Diagnostics CEO & co-founder Yossi Pollak said in the release. “We’re glad to have Koch Disrup…

Read more
  • 0